Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Special Features of Adaptive Immunity01:20

Special Features of Adaptive Immunity

The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retraction Note: Selinexor (KPT-330) has antitumor activity against anaplastic thyroid carcinoma in vitro and in vivo and enhances sensitivity to doxorubicin.

Scientific reports·2025
Same author

Retraction Note: Kinase profiling of liposarcomas using RNAi and drug screening assays identified druggable targets.

Journal of hematology & oncology·2025
Same author

Sinus and palatal Rosai-Dorfman Disease: Case report and review of the literature.

American journal of otolaryngology·2025
Same author

Targeting RNA Exonuclease XRN1 Potentiates Efficacy of Cancer Immunotherapy.

Cancer research·2023
Same author

HIV, pathology and epigenetic age acceleration in different human tissues.

GeroScience·2022
Same author

Central nervous system ALK-negative anaplastic large cell lymphoma with IRF4/DUSP22 rearrangement.

Brain tumor pathology·2021

Related Experiment Video

Updated: May 16, 2026

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
09:02

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

Aggressive B-cell lymphomas: how many categories do we need?

Jonathan W Said1

  • 1Department of Pathology, David Geffen School of Medicine, University of California-Los Angeles, CA 90095, USA. jsaid@mednet.ucla.edu

Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|November 17, 2012
PubMed
Summary
This summary is machine-generated.

Aggressive B-cell lymphomas, including diffuse large B-cell lymphoma (DLBCL) and Burkitt lymphoma (BL), have distinct features. This report focuses on clinically aggressive DLBCL subtypes and their relationship to BL.

More Related Videos

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma
15:07

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma

Published on: December 28, 2015

Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma
07:52

Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma

Published on: January 9, 2019

Related Experiment Videos

Last Updated: May 16, 2026

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
09:02

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma
15:07

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma

Published on: December 28, 2015

Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma
07:52

Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma

Published on: January 9, 2019

Area of Science:

  • Hematology
  • Oncology
  • Pathology

Background:

  • Aggressive B-cell lymphomas are a varied group of neoplasms originating from different B-cell developmental stages.
  • These lymphomas encompass subtypes of diffuse large B-cell lymphoma (DLBCL), Burkitt lymphoma (BL), mantle cell lymphoma, and B lymphoblastic lymphoma.

Purpose of the Study:

  • To identify and characterize clinically aggressive subtypes of DLBCL.
  • To explore the relationship between DLBCL and BL, including the intermediate category (B-cell lymphoma unclassifiable with features intermediate between DLBCL and BL).

Main Methods:

  • Histological analysis
  • Cytogenetic and molecular abnormality assessment
  • Tumor microenvironment relationship evaluation

Main Results:

  • Distinct signatures for aggressive B-cell neoplasms are defined by histological, cytogenetic, and molecular features.
  • These signatures can indicate potential therapeutic targets.
  • The study focuses on specific DLBCL subtypes and their classification relative to BL.

Conclusions:

  • Understanding the specific signatures of aggressive B-cell lymphomas is crucial for targeted therapy.
  • Further characterization of DLBCL subtypes and their relationship with BL is needed for improved classification and treatment.